New U.S. dietary guidelines push meat and animal-based products while underplaying plant-based vegetarian options. More balanced public health messaging may be warranted.

Discontinuing obesity medicines means the weight comes back and people lose the cardiovascular and metabolic benefits conferred by the drugs.

Greenland sharks maintain sharp vision for centuries, revealing powerful DNA repair and eye-protection strategies that may inspire future approaches to lifelong human eyesight.

An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle strength, mobility, and survival.

If a political debate takes place this year on the topic of ACA cost containment and the affordability of premiums, it’s hoped that reform initiatives won’t be piecemeal.

A new mRNA-based method reprograms immune cells directly inside solid tumors, boosting anti-cancer activity and paving the way for next-generation therapies.

Convenience of an oral pill may be critical to some patients. This could expand the market but also improve patient persistence and sustainability of long-term outcomes.

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the future of genetic medicine and patient care.

Differences in vaccination policies illustrate the importance of context, regarding distinct healthcare systems and the vaccine stance taken by public health officials.

Childhood vaccine schedules among U.S. peers differ marginally. Unlike the U.S., however, peer health officials don’t sow doubt among the public about vaccination.